Trial · NCT00869050
Adverse events31
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 31
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pain abdomen | Gastrointestinal disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Erythema | Skin and subcutaneous tissue disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Facial flushing | Skin and subcutaneous tissue disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Fatigue | General disorders | Capecitabine and Temozolomide | 5 | 38 | 5 |
| other | Dizziness | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Night sweats | General disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Vomiting | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Capecitabine and Temozolomide | 5 | 38 | 5 |
| other | Confusion | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Loss of apetite | General disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Arm and ankle pain | Musculoskeletal and connective tissue disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Liver pain | Gastrointestinal disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Infection | Infections and infestations | Capecitabine and Temozolomide | 5 | 38 | 5 |
| other | Nail changes | Skin and subcutaneous tissue disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Nausea | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Cough | General disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Constipation | General disorders | Capecitabine and Temozolomide | 4 | 38 | 4 |
| other | Edema | General disorders | Capecitabine and Temozolomide | 2 | 38 | 2 |
| other | Mucositis | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
| other | Tingling lower lip | General disorders | Capecitabine and Temozolomide | 1 | 38 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00869050/events